← The Wire
HALONasdaq
HALOZYME THERAPEUTICS, INC.
Biological Products, (No Diagnostic Substances) · DE · CIK 1159036
Halozyme Therapeutics develops and licenses drug delivery technologies to improve patient experiences with injected therapies
red 8-K · 90d
$8.24B
Market cap
$77.18
Last close
+3.0%
1D
+11.9%
5D
2.2M
Volume
Price · last 39 sessions+19.5%
May 4L $64.12 · H $77.18Jun 29
291
Total filings
May 11, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 11, 20268-KResults of OperationsMay 11, 20268-KShareholder VoteMay 7, 20268-KExecutive ChangeApr 30, 20268-KBylaw AmendmentApr 24, 2026DEFA14ADEFA14AMar 23, 2026DEF 14ADEF 14AMar 23, 20268-KExecutive ChangeMar 12, 202610-K10-KFeb 17, 20268-KResults of OperationsFeb 17, 20268-KResults of OperationsJan 28, 20268-KExecutive ChangeDec 9, 20258-KExecutive ChangeDec 8, 20258-KExecutive ChangeNov 24, 20258-KMaterial Agreement · New Debt / ObligationNov 12, 20258-KCompany UpdateNov 7, 20258-KMaterial Agreement · New Debt / ObligationNov 5, 202510-Q10-QNov 3, 20258-KExecutive Change · Results of OperationsNov 3, 20258-KReg FD DisclosureOct 14, 20258-KExecutive ChangeOct 6, 20258-KMaterial AgreementOct 3, 20258-KReg FD DisclosureOct 1, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 20258-KShareholder VoteMay 2, 20258-KExecutive ChangeMar 21, 2025DEFA14ADEFA14AMar 18, 2025DEF 14ADEF 14AMar 18, 202510-K10-KFeb 18, 20258-KResults of OperationsFeb 18, 20258-KExecutive ChangeFeb 13, 20258-KResults of OperationsJan 8, 202510-Q10-QOct 31, 20248-KResults of OperationsOct 31, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 20248-KShareholder VoteApr 26, 2024DEFA14ADEFA14AMar 15, 2024DEF 14ADEF 14AMar 15, 202410-K10-KFeb 20, 20248-KResults of OperationsFeb 20, 20248-KResults of OperationsJan 17, 202410-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KCompany UpdateSep 7, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 20238-KShareholder VoteMay 8, 2023DEFA14ADEFA14AMar 24, 2023DEF 14ADEF 14AMar 24, 20238-KReg FD DisclosureMar 16, 20238-KCompany UpdateMar 13, 20238-KExecutive ChangeFeb 23, 202310-K10-KFeb 21, 20238-KResults of OperationsFeb 21, 20238-KExecutive ChangeFeb 6, 2023SC 13GSC 13GJan 20, 20238-KResults of Operations · Reg FD DisclosureJan 10, 202310-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KMaterial Agreement · New Debt / ObligationAug 19, 20228-KMaterial Agreement · New Debt / ObligationAug 18, 20228-KCompany UpdateAug 16, 20228-KCompany UpdateAug 15, 20228-K/ACompany UpdateAug 9, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 20228-KMaterial Agreement · Acquisition / DispositionMay 24, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 20228-KShareholder VoteMay 6, 2022DEFA14ADEFA14AApr 18, 20228-KMaterial Agreement · Reg FD DisclosureApr 13, 2022
Insider Activity
In the 90 days to Mar 10, 2026: 3 sold $9.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Caudill CortneySVP, CHIEF OPERATING OFFICER | Sell | 8,857 | $67.64 | $599K |
| Mar 9, 2026 | Caudill CortneySVP, CHIEF OPERATING OFFICER | Sell | 17,900 | $67.75 | $1.2M |
| Mar 9, 2026 | Caudill CortneySVP, CHIEF OPERATING OFFICER | Sell | 2,100 | $68.25 | $143K |
| Mar 4, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 7,329 | $69.94 | $513K |
| Mar 4, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 2,671 | $70.95 | $190K |
| Mar 3, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 13,481 | $68.85 | $928K |
| Mar 3, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 6,519 | $69.33 | $452K |
| Mar 2, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 15,322 | $69.80 | $1.1M |
| Mar 2, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 4,100 | $69.20 | $284K |
| Mar 2, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 578 | $70.46 | $41K |
| Feb 5, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 5,376 | $78.38 | $421K |
| Feb 5, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 4,624 | $78.94 | $365K |
| Feb 4, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 10,100 | $77.54 | $783K |
| Feb 4, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 9,900 | $76.94 | $762K |
| Feb 3, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 9,659 | $75.94 | $734K |
| Feb 3, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 7,790 | $76.73 | $598K |
| Feb 3, 2026 | Torley HelenPRESIDENT AND CEO | Sell | 2,551 | $74.88 | $191K |
| Jan 5, 2026 | Connaughton BernadetteDirector | Sell | 2,000 | $70.25 | $141K |
| Dec 1, 2025 | Torley HelenPRESIDENT AND CEO | Sell | 10,406 | $68.51 | $713K |
| Dec 1, 2025 | Torley HelenPRESIDENT AND CEO | Sell | 5,402 | $69.44 | $375K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance